IND-enabling Studies for Platform Clinical Trials of Genome Editing in Multiple Diseases (U01 Clinical Trial Not Allowed)
The Somatic Cell Genome Editing (SCGE) Common Fund Program new funding announcement.
Contact: Dr. PJ Brooks
Notice of NHLBI Participation (NOT-HL-24-012)
Notice of NINDS Participation (NOT-NS-24-068)
Issued by:
National Institute of Allergy and Infectious Diseases (NIAID)
National Center for Advancing Translational Sciences (NCATS)
National Cancer Institute (NCI)